Tag Archives: Non-Maleficence and Beneficence

NICE Drugs Policy and the Elderly (NHS Choices)

Summary News of a Department of Health consultation, which involves asking the National Institute for Health and Care Excellence (NICE) to consider “wider societal benefits” (in addition to the burden of illness and the impact a disease has on patients) … Continue reading

Posted in Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), In the News, Management of Condition, National, NHS, NHS Digital (Previously NHS Choices), NICE Guidelines, Non-Pharmacological Treatments, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment